208 related articles for article (PubMed ID: 27175585)
1. Intestine-specific homeobox (ISX) upregulates E2F1 expression and related oncogenic activities in HCC.
Wang SN; Wang LT; Sun DP; Chai CY; Hsi E; Kuo HT; Yokoyama KK; Hsu SH
Oncotarget; 2016 Jun; 7(24):36924-36939. PubMed ID: 27175585
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory homeobox gene, ISX, regulates tumor growth and survival in hepatocellular carcinoma.
Hsu SH; Wang LT; Lee KT; Chen YL; Liu KY; Suen JL; Chai CY; Wang SN
Cancer Res; 2013 Jan; 73(2):508-18. PubMed ID: 23221382
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor promotes hepatocellular carcinoma tumorigenesis by targeting intestine-specific homeobox expression.
Hsu SH; Wang LT; Chai CY; Wu CC; Hsi E; Chiou SS; Wang SN
Mol Carcinog; 2017 Oct; 56(10):2167-2177. PubMed ID: 28398627
[TBL] [Abstract][Full Text] [Related]
4. Intestine-Specific Homeobox Gene
Wang LT; Chiou SS; Chai CY; Hsi E; Yokoyama KK; Wang SN; Huang SK; Hsu SH
Cancer Res; 2017 Aug; 77(15):4065-4077. PubMed ID: 28625979
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of intestine-specific homeobox by ERK1 modulates oncogenic activity and sorafenib resistance.
Wang LT; Liu KY; Chiou SS; Huang SK; Hsu SH; Wang SN
Cancer Lett; 2021 Nov; 520():160-171. PubMed ID: 34265398
[TBL] [Abstract][Full Text] [Related]
6. Impact of bromodomain-containing protein 4 (BRD4) and intestine-specific homeobox (ISX) expression on the prognosis of patients with hepatocellular carcinoma' for better clarity.
Chuang KT; Wang SN; Hsu SH; Wang LT
Cancer Med; 2021 Aug; 10(16):5545-5556. PubMed ID: 34173348
[TBL] [Abstract][Full Text] [Related]
7. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
8. SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.
Gu Y; Wang X; Liu H; Li G; Yu W; Ma Q
Oncol Rep; 2018 Oct; 40(4):1863-1874. PubMed ID: 30106440
[TBL] [Abstract][Full Text] [Related]
9. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.
Sun HX; Xu Y; Yang XR; Wang WM; Bai H; Shi RY; Nayar SK; Devbhandari RP; He YZ; Zhu QF; Sun YF; Hu B; Khan M; Anders RA; Fan J
Hepatology; 2013 Mar; 57(3):1088-97. PubMed ID: 23212661
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
12. E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer.
Ladu S; Calvisi DF; Conner EA; Farina M; Factor VM; Thorgeirsson SS
Gastroenterology; 2008 Oct; 135(4):1322-32. PubMed ID: 18722373
[TBL] [Abstract][Full Text] [Related]
13. Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.
Duan Y; Tian L; Gao Q; Liang L; Zhang W; Yang Y; Zheng Y; Pan E; Li S; Tang N
Oncotarget; 2016 Jul; 7(29):45863-45875. PubMed ID: 27351279
[TBL] [Abstract][Full Text] [Related]
14. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
Sang XB; Zong ZH; Wang LL; Wu DD; Chen S; Liu BL; Zhao Y
Oncotarget; 2017 Feb; 8(9):14777-14793. PubMed ID: 28146423
[TBL] [Abstract][Full Text] [Related]
15. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
16. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
17. Intestine-specific homeobox (ISX) induces intestinal metaplasia and cell proliferation to contribute to gastric carcinogenesis.
Sue S; Shibata W; Kameta E; Sato T; Ishii Y; Kaneko H; Miwa H; Sasaki T; Tamura T; Kondo M; Maeda S
J Gastroenterol; 2016 Oct; 51(10):949-60. PubMed ID: 26872890
[TBL] [Abstract][Full Text] [Related]
18. CAMK2N1 suppresses hepatoma growth through inhibiting E2F1-mediated cell-cycle signaling.
Peng JM; Tseng RH; Shih TC; Hsieh SY
Cancer Lett; 2021 Jan; 497():66-76. PubMed ID: 33068700
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression.
Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanisms.
Jin Y; Liang ZY; Zhou WX; Zhou L
Hepatol Int; 2019 Mar; 13(2):180-189. PubMed ID: 30600477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
